Meddenovo Drug Design
Meddenovo Drug Design leverages AI, molecular modeling, and cyclic peptides to create innovative therapeutic solutions. Their platform is uniquely designed to harness the potential of cyclic peptides, aiming to accelerate drug development and reduce time to market for treatments of diseases like cancer and autoimmune disorders.
Funding Round: Pre-Seed
Funding Amount: €1M
Date: 31-Jul-2024
Investors: ACT Venture Partners
Markets: Biotech, Pharmaceuticals, AI, Drug Discovery, Biotechnology Research
HQ: Villeurbanne, Auvergne-Rhône-Alpes, France
Founded: 2021
Website: https://meddenovo.com/
LinkedIn: https://www.linkedin.com/company/meddenovo-drug-design
Crunchbase: https://www.crunchbase.com/organization/meddenovo-drug-design
Leave a Comment
Comments
No comments yet.